|
Re: 48 hours
|
6
|
Resverlogix Corp.
|
Nov 14, 2019 03:15PM
|
|
Re: Updated Analyst Report from Marcel Wijma, Van Leeuwenhoeck Institute
|
6
|
Resverlogix Corp.
|
Feb 02, 2018 12:37PM
|
|
Re: Nature Article on the role of Endothelial Cells in COVID 19
|
6
|
Resverlogix Corp.
|
May 24, 2020 12:53AM
|
|
Re: The cardiac pre-print now published....in Cell!
|
6
|
Resverlogix Corp.
|
Mar 17, 2021 02:00AM
|
|
Re: Interesting read while we wait for eGFR news
|
6
|
Resverlogix Corp.
|
Mar 20, 2020 11:52PM
|
|
Re: What if a deal is in the works?
|
6
|
Resverlogix Corp.
|
Sep 17, 2019 03:48PM
|
|
Re: Can anyone say....
|
6
|
Resverlogix Corp.
|
Sep 25, 2019 04:28AM
|
|
Re: Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes
|
6
|
Resverlogix Corp.
|
Aug 29, 2023 01:39PM
|
|
Re: RESVERLOGIX ANNOUNCES. $15.1 MILLION OF PRIVATE PLACEMENTS
|
6
|
Resverlogix Corp.
|
Apr 01, 2019 04:43PM
|
|
Re: Questions about the Medison licensing agreement....
|
6
|
Resverlogix Corp.
|
Jan 12, 2018 12:27AM
|
|
Re: Veru's stock nearly triples after oral COVID-19 treatment leads to 'statistically meaningful' reduction in deaths.
|
6
|
Resverlogix Corp.
|
Apr 11, 2022 07:47PM
|
|
Re: Clovis' Rubracra
|
6
|
Zenith Epigenetics
|
Oct 05, 2018 03:18AM
|
|
Re: IND filing for Renal Trial
|
6
|
Resverlogix Corp.
|
Mar 20, 2017 11:11PM
|
|
Re: Optimistic
|
6
|
Resverlogix Corp.
|
Oct 14, 2021 10:27PM
|
|
Re: I'm glad the SSRA issue has finally been put to bed....
|
6
|
Resverlogix Corp.
|
Sep 18, 2018 02:24AM
|
|
Re: Vas. Dementia pipeline RVX?
|
6
|
Resverlogix Corp.
|
Dec 07, 2022 05:11PM
|
|
Re: ... listened to webcast a couple times...
|
6
|
Zenith Epigenetics
|
Sep 13, 2018 12:19AM
|
|
Re: Presentation slides are up
|
6
|
Zenith Epigenetics
|
Jun 18, 2020 12:06PM
|
|
Re: RVX-Zenith
|
6
|
Resverlogix Corp.
|
Jan 29, 2017 07:02PM
|
|
Re: What if
|
6
|
Resverlogix Corp.
|
Mar 06, 2019 11:13AM
|
